MARKET

NXLIW

Nexalin Tech
NXLIW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0167
1.087
0.0403
-
Nexalin Technology Partners with UC San Diego to Launch AI-Driven NeuroCare Virtual Clinic
Reuters · 4d ago
Nexalin Technology Validates DIFS™ Neurostimulation with New Clinical Research Across Multiple Brain Disorders
Reuters · 02/02 13:45
NEXALIN TECHNOLOGY RECEIVES NASDAQ LISTING STATUS NOTIFICATION
Reuters · 01/23 22:15
Nexalin Technology Neurostimulation Device Shows Significant ADHD Symptom Improvement in Clinical Study
Reuters · 01/14 14:00
Nexalin Advances Non-Invasive Alzheimer's Therapy Toward FDA Clinical Trials
Reuters · 12/03/2025 13:03
NEXALIN TECHNOLOGY INC - REVIEWED ENDPOINTS FOR ALZHEIMER'S OUTCOMES INCLUDING COGNITIVE ASSESSMENTS
Reuters · 12/03/2025 13:01
NEXALIN TECHNOLOGY COMPLETES FDA Q-SUBMISSION MEETING FOR GEN-2 SYNC™ NEUROSTIMULATION CONSOLE IN ALZHEIMER’S DISEASE PROGRAM
Reuters · 12/03/2025 13:00
NEXALIN TECHNOLOGY INC: INTENDS TO INCORPORATE FDA'S FEEDBACK FROM Q-SUB MEETING INTO ITS FINAL PILOT STUDY PROTOCOL
Reuters · 12/03/2025 13:00
More

Webull offers Nexalin Tech stock information, including NASDAQ: NXLIW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NXLIW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NXLIW stock methods without spending real money on the virtual paper trading platform.